Skip to content

Corruption Ledger

The Public Ledger of Corruption

  • About
  • Corruption
    • banks
    • corporate
    • environment
    • government
    • health
    • Leaks
    • misinformation
    • privacy and surveillance
    • Protest and Unrest
  • Sanctions
    • Sanctions News
    • Global Sanctions Feed
    • European Sanctions Feed
    • Canadian Sanctions Feed
    • US Sanctions Feed
  • Regions
    • Asias
    • Europe
    • Middle East
    • Oceania
    • US & Canada
    • World
  • Enforcement
  • Economy
  • International Conflict
  • Tech
  • Cryptocurrency
  • Free Speech
  • Toggle search form
  • Deutsche Bank Stock Tumbles On Contagion Fears All News
  • Wall St falls as bank contagion fears flare up All News
  • US due diligence firm Mintz Group says staff detained in China after office raid _enforcement
  • China insists it is impartial on Russia-Ukraine, questions US ‘pouring weapons into the conflict’ All Regions
  • China Denounces Submarine Deal Aerospace
  • Russian tech giants appeal Nasdaq delisting All Regions
  • US credit card debt at record high as Fed raises rates again All Regions
  • Russia boosts defenses near Japan; accuses U.S. of expanding Asia-Pacific presence All Regions

Pfizer strikes $43bn deal for cancer drug innovator Seagen

Posted on March 13, 2023March 14, 2023 By CorruptionLedger No Comments on Pfizer strikes $43bn deal for cancer drug innovator Seagen

The pharmaceutical giant says it will pay $229 in cash for each share of Seagen.

The pharmaceutical giant Pfizer has struck a $43bn deal for biotech company Seagen to add innovative targeted therapies to its portfolio of cancer treatments.

Monday’s deal is Pfizer’s biggest in a string of acquisitions after a cash windfall from its COVID-19 vaccine and pill. The acquisition will add four approved cancer therapies with combined sales of nearly $2bn in 2022.

Pfizer said Monday that it will pay $229 in cash for each share of Seagen. It then plans to let the biotech drug developer “continue innovating” except with more resources than it would have alone, Pfizer Chairman and CEO Albert Bourla told analysts.

“We are not buying the golden eggs,” he said. “We are acquiring the goose that is laying the golden eggs.”

Bothell, Washington-based Seagen specialises in working with antibody drug conjugate, or ADC, technology. Its key products use lab-made proteins called monoclonal antibodies that seek out cancer cells to help deliver a cancer-killing drug while sparing surrounding tissue.

Cancer treatments are a priority for Pfizer. They brought in $12bn in revenue for the drugmaker last year. But Pfizer has marketed only a couple first-generation ADC treatments, a spokeswoman said.

Seagen has four treatments on the market. It also has a pipeline of drugs under development that include potential treatments for a form of lung cancer and advanced breast cancer.

“We think this really changes dramatically the oncology presence of Pfizer, makes it one of a kind,” Bourla said.

Seagen’s top seller, Adcetris, treats lymph system cancers. It had $839m in sales last year, a 19 percent increase over the previous year.

Seagen also has a deal with Pfizer’s Array BioPharma to develop, make and sell the breast and colorectal cancer treatment Tukysa. It brought in $353m in sales for Seagen last year.

The company, which changed its name from Seattle Genetics in 2020, saw total revenue grow about 25 percent last year to nearly $2bn. Seagen also shaved its loss to $610m from $674m in 2021.

The drug developer predicts about $2.2bn in sales for this year.

Pfizer booked about $100bn in total revenue last year and has been flush with cash thanks to sales of its COVID-19 vaccine Comirnaty and treatment Paxlovid.

Bourla said this year that the company planned to use its “extraordinary firepower” to buy products that will deliver $25bn in incremental revenue by 2030.

The deal announced Monday and some previous acquisitions will help Pfizer account for most of that. But Bourla emphasised on Monday that the company expects Seagen’s contributions to extend beyond the end of the decade.

New York-based Pfizer has already spent $11.6bn on migraine treatment developer Biohaven Pharmaceutical. It also spent $5.4bn on sickle cell disease treatment maker Global Blood Therapeutics and bought Arena Pharmaceuticals for another $6.7bn.

The drugmaker needs more revenue sources in part because it faces the expiration of patents protecting drugs like its breast cancer treatment Ibrance from cheaper competition in the coming years.

Pfizer said Monday that it will pay for Seagen mostly through $31bn in new, long-term debt.

Both companies’ boards have unanimously approved the deal. But regulators still need to look at it, and Seagen shareholders will have to approve it.

Source: https://www.aljazeera.com/news/2023/3/13/pfizer-buys-seagen-for-43bn-boosts-access-to-cancer-drugs

All Regions, corporate corruption, Corruption, government corruption, health, Region Americas, Region Europe, Region US & Canada, x.aljazeera Tags:z.aljazeera

Post navigation

Previous Post: Kremlin critic Kara-Murza goes on trial for treason
Next Post: US / Russia sanctions ‘evasion brokers’

See also

  • Central African Republic: Said trial opens at International Criminal Court Corruption
  • Russia cuts off gas to Poland and Bulgaria. Who in Europe is next? All Regions
  • Credit Suisse Shares Plunge as Bank Storm Spreads to Europe All Regions
  • Putin says Germany remains ‘occupied’ All Regions
  • Court Orders Five Defendants in International Ponzi Scheme to Pay Over $13.1 Million Corruption
  • AU / Banks to pay $4.7 billion in compensation to customers (AMP, ANZ, CBA, Macquarie, NAB and Westpac) _enforcement

You must log in to post a comment.

  • Deutsche Bank Stock Tumbles On Contagion Fears
  • Wall St falls as bank contagion fears flare up
  • US due diligence firm Mintz Group says staff detained in China after office raid
  • Credit Suisse, UBS facing US Russia-sanctions probe, subpoenas also sent to employees major US banks
  • (US) Appeals court sides with Justice Department in Trump lawyer fight
  • Russia boosts defenses near Japan; accuses U.S. of expanding Asia-Pacific presence
  • US credit card debt at record high as Fed raises rates again
  • Russian tech giants appeal Nasdaq delisting
  • China Denounces Submarine Deal
  • China insists it is impartial on Russia-Ukraine, questions US ‘pouring weapons into the conflict’
  • German ambassador confirms that Putin would be arrested if he entered Germany
  • Danish Navy present near Nord Stream 2 – media
  • Railroad reluctant to say who OK’d chemical burn after Ohio derailment
  • Scientists insist on continuing search for toxics in East Palestine
  • Top aide of Canadian PM Trudeau will testify in parliament on Chinese election meddling
  • Zuckerberg, Meta sued for failing to address sex trafficking, child exploitation
  • Norfolk Southern: Independent group finds toxic chemicals that Ohio EPA didn’t – Ohio train derailment (East Palestine)
  • JP Morgan, Deutsche Bank to face lawsuit over Epstein ties
  • Putin announces readiness to switch to the Chinese Yuan currency in foreign trade
  • Putin and Xi sign two documents in Moscow
  • Russia says jet scrambled as US B-52 bombers fly over Baltic Sea
  • Paris police, protesters clash for third night over Macron’s pension reform
  • Global / ChipMixer software ‘taken down’ by multi-national law enforcement coalition
  • Russian officials scoff at ICC’s indictment of Putin
  • SVB parent company files for bankruptcy
  • Violent protests in France over Macron’s retirement age push
  • International court issues war crimes warrant for Putin
  • US / Chinese tycoon and Bannon ally Guo Wengui charged with $1bn fraud
  • Samsung to invest $230 billion to build mega chip cluster
  • Pentagon calls Moscow over drone incident
  • Credit Suisse slump renews fears of global banking crisis
  • Silicon Valley Bank execs, parent company sued after collapse
  • Credit Suisse Shares Plunge as Bank Storm Spreads to Europe
  • Dow tumbles nearly 500 points as Credit Suisse stokes fears of bank failure contagion
  • Russian jet, US drone crash over Black Sea, US military says
  • Dark hours for Credit Suisse Bank
  • Account full of holes at Credit Suisse
  • Russia blasts Canada over ‘regime change’
  • US / Sterling Bancorp, Inc. to Plead Guilty to $69M Securities Fraud
  • US drones have no business near Russia – ambassador
  • Inflation in Argentina surges past 100 percent in historic spike
  • Paris visitors alarmed at trash strike
  • China says AUKUS on ‘dangerous path’ with nuclear subs deal
  • Taiwan unveils portable attack drone as China tensions rise
  • Putin rejects theory about Ukrainian role in pipeline blasts
  • Syrian president Assad arrives in Moscow, set to meet Putin
  • Marin’s F-18 proposal fizzles, as a new Finnish NATO tack emerges
  • Ohio sues Norfolk Southern over toxic train derailment
  • US / ‘Forever chemicals’ in drinking water
  • Nord Stream blasts staged by a state-level actor – Putin
  • No Harvey Weinstein retrial on rape, sex assault charges
  • US / Silicon Valley Bank execs, parent company sued after collapse
  • As U.S. steps back from Middle East, China steps in
  • Western sanctions shielding Russian financial system from global crisis – Kremlin
  • Moody’s puts US banks on notice
  • Robert Kiyosaki predicts next big bank to fold
  • UK $6 billion defense boost targets atomic submarines, weapons top-up
  • BBC gets £20 million boost from UK govt
  • Document reveals why Canada arms Saudi Arabia – media
  • Taiwan braces for ‘total blockade’ – media
  • Biden administration lets Ukrainians who fled war stay in US
  • Ratings Deceit: S&P sued for deceitful CDO ratings
Rumble Video

Corruption Ledger Follow

The Public ▇▇▇ Ledger of ▇▇▇ Corruption. https://t.co/wkobrEotQR

5amResearch
Corruption Ledger @5amresearch ·
10 Feb

News Coverage of the September 2022 #NordStream Pipeline Attack https://corruptionledger.com/news-coverage-of-the-september-2022-nord-stream-pipeline-attack/ via @5amResearch

Reply on Twitter 1623868066818928641 Retweet on Twitter 1623868066818928641 Like on Twitter 1623868066818928641
Corruption Ledger @5amresearch ·
10 Feb

Mia Jankowicz of Business Insider calls Pulitzer prize-winning journalist Seymore Harsh a "discredited journalist." #NordStream

Reply on Twitter 1623857264086974464 Retweet on Twitter 1623857264086974464 Like on Twitter 1623857264086974464 1
Corruption Ledger @5amresearch ·
9 Feb

#Kraken to Discontinue Unregistered Offer and Sale of Crypto Asset Staking-As-A-Service Program and Pay $30 Million to Settle SEC Charges
https://www.sec.gov/news/press-release/2023-25

Reply on Twitter 1623815305452560384 Retweet on Twitter 1623815305452560384 Like on Twitter 1623815305452560384
Corruption Ledger @5amresearch ·
9 Feb

SpaceX: Ukraine breaching agreement, weaponizing Starlink https://en.mdn.tv/71FW

Reply on Twitter 1623685510496505860 Retweet on Twitter 1623685510496505860 Like on Twitter 1623685510496505860
Load More

–

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2022 Corruption Ledger. This web site contains no ads.